Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Ullrich

Showing results (21-30 of 130) with videos related to

Pageof 13
Sort By:
Trends in Molecular Medicine|February 14, 2002
Receptor tyrosine kinases as targets for anticancer drugsEsther Zwick, Johannes Bange, Axel Ullrich
Nature Reviews. Cancer|May 4, 2004
The discovery of receptor tyrosine kinases: targets for cancer therapyAndreas Gschwind, Oliver M Fischer, Axel Ullrich
Cancer Research|March 18, 2004
Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptorStefan Hart, Oliver M Fischer, Axel Ullrich
Cancer Cell|June 28, 2002
Smart drugs: tyrosine kinase inhibitors in cancer therapyLaura K Shawver, Dennis Slamon, Axel Ullrich
Methods in Molecular Biology (Clifton, N.J.)|June 20, 2006
Dissecting the epidermal growth factor receptor signal transactivation pathwayOliver M Fischer, Stefan Hart, Axel Ullrich
Molecular Oncology|July 31, 2012
Inhibition of doxorubicin-induced HER3-PI3K-AKT signalling enhances apoptosis of ovarian cancer cellsMartin Bezler, Jan G Hengstler, Axel Ullrich
The Journal of Biological Chemistry|September 1, 2004
Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survivalBeatrix Schäfer, Beatrice Marg, Andreas Gschwind, et al.
Nature Reviews. Microbiology|April 15, 2004
Interplay between mycobacteria and host signalling pathwaysAnil Koul, Thomas Herget, Bert Klebl, et al.
International Journal of Cancer|November 13, 2008
UV-induced EGFR signal transactivation is dependent on proligand shedding by activated metalloproteases in skin cancer cell linesBhuminder Singh, Matthias Schneider, Pjotr Knyazev, et al.
Oncotarget|November 7, 2014
Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 statusZhiguang Xiao, Bianca Sperl, Axel Ullrich, et al.
Pageof 13

Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Trends in Molecular Medicine|February 14, 2002
Receptor tyrosine kinases as targets for anticancer drugsEsther Zwick, Johannes Bange, Axel Ullrich
Nature Reviews. Cancer|May 4, 2004
The discovery of receptor tyrosine kinases: targets for cancer therapyAndreas Gschwind, Oliver M Fischer, Axel Ullrich
Cancer Research|March 18, 2004
Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptorStefan Hart, Oliver M Fischer, Axel Ullrich
Cancer Cell|June 28, 2002
Smart drugs: tyrosine kinase inhibitors in cancer therapyLaura K Shawver, Dennis Slamon, Axel Ullrich
Methods in Molecular Biology (Clifton, N.J.)|June 20, 2006
Dissecting the epidermal growth factor receptor signal transactivation pathwayOliver M Fischer, Stefan Hart, Axel Ullrich
Molecular Oncology|July 31, 2012
Inhibition of doxorubicin-induced HER3-PI3K-AKT signalling enhances apoptosis of ovarian cancer cellsMartin Bezler, Jan G Hengstler, Axel Ullrich
The Journal of Biological Chemistry|September 1, 2004
Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survivalBeatrix Schäfer, Beatrice Marg, Andreas Gschwind, et al.
Nature Reviews. Microbiology|April 15, 2004
Interplay between mycobacteria and host signalling pathwaysAnil Koul, Thomas Herget, Bert Klebl, et al.
International Journal of Cancer|November 13, 2008
UV-induced EGFR signal transactivation is dependent on proligand shedding by activated metalloproteases in skin cancer cell linesBhuminder Singh, Matthias Schneider, Pjotr Knyazev, et al.
Oncotarget|November 7, 2014
Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 statusZhiguang Xiao, Bianca Sperl, Axel Ullrich, et al.
Pageof 13